ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020
Porous Aromatic Framework with Tailored Binding Sites and Pore Sizes as a High-Performance Hemoperfusion Adsorbent for Bilirubin Removal.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 92 citations in OpenAlex.
- Tailor-Made Nanoporous Metal-Organic Frameworks Via Molecular Engineering for Bilirubin-Specific Capture from Liver Failure Patients' Blood.Nano-micro letters · 2026Article
- Heterojunction-Engineered g-CMolecules (Basel, Switzerland) · 2025Article
- From Radioactive Effluent to Drinking Water: Efficient Removal of TraceAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
- High-performance HScience advances · 2024Article
- Nanoparticles Fueled by Enzyme for the Treatment of Hyperlipidemic Acute Pancreatitis.ACS biomaterials science & engineering · 2024Article
- Biomedical Metal-Organic Framework Materials: Perspectives and Challenges.Advanced functional materials · 2024Article
- [Application of Modified Polyether Sulfone Microspheres in Hyperbilirubinemia].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024Article
- Article
- Nanofibrous Porous Organic Polymers and Their Derivatives: From Synthesis to Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024Review
- Metal-organic framework (UiO-66 and UiO-66-NHRSC advances · 2023Article
- A breakthrough trial of an artificial liver without systemic heparinization in hyperbilirubinemia beagle models.Bioactive materials · 2023Article
- Flexible organic frameworks sequester neuromuscular blocking agentsChemical science · 2022Article
- Polymyxin B engineered polystyrene-divinylbenzene microspheres for the adsorption of bilirubin and endotoxin.RSC advances · 2021Article
- Hydroxyapatite reinforced inorganic-organic hybrid nanocomposite as high-performance adsorbents for bilirubin removalBioactive materials · 2021Article
- Ultraefficiently Calming Cytokine Storm Using TiSmall methods · 2021Article
- Porous Aromatic Framework with Tailored Binding Sites and Pore Sizes as a High-Performance Hemoperfusion Adsorbent for Bilirubin Removal.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Highly efficient removal of bilirubin from blood by hemoperfusion for liver failure therapy remains a challenge in the clinical field due to the low adsorption capacity and slow adsorption kinetics of currently used bilirubin adsorbents (e.g., activated carbon and ion-exchange resin). Recently, porous aromatic frameworks (PAFs) with high surface areas, tunable structures, and remarkable stability provide numerous possibilities to obtain satisfying adsorbents. Here, a cationic PAF with more mesopores, named iPAF-6, is successfully constructed via a de novo synthetic strategy for bilirubin removal. The prepared iPAF-6 exhibits a record-high adsorption capacity of 1249 mg g
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.